PATENT CLAIM ANALYSIS

Application Number: 15987505
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "356000"]

Abstract:
The present application relates to topical formulations in the form of an oil-in-water emulsion comprising nifedipine and a photostabilizing effective amount of quercetin or a photostabilizing effective amount of a combination of quercetin and butyl methoxydibenzoylmethane (BMDBM). Such topical formulations may, for example, be used for the treatment of diseases, disorders or conditions that benefit from topical administration of nifedipine such as but not limited to Raynaud phenomenon, chilblains or wound healing.

Claim (Index 13):
The topical formulation of  claim 1 , wherein the topical formulation is formulated for transdermal delivery of the nifedipine to the subject.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 93.0
- Lexical Diversity: 1.45455
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13503458', '15147715', '15506821', '15272826', '15198728']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7722521982630145
- 35 USC 102 Novelty (BERT): 0.4821250338977133
- Combined Prediction Score: 0.7432394818264844
- Mean Citation Score: 172.61357199999995
- Max Citation Score: 177.34114
- Similarity Product: 128.35286900405885

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test